Proteinuria >0.5 g/d, a prevalent prognostic factor for patient and graft survival in kidney transplantation

Clinical Transplantation

Volumn 24, Issue 2, 2010, Pages 175-180

  Cantarovich, Félix ^a   Martinez, Frank ^a   Heguilen, Ricardo ^b   Thervet, Eric ^a   Mamzer Bruneel, Marie France ^a   Gonzalez, Claudio ^c   Legendre, Christophe ^a  

^a HÔPITAL NECKER ENFANTS MALADES   (France)

^b Hospital JA Fernández   (Argentina)

^c UNIVERSIDAD DE BUENOS AIRES   (Argentina)

Author keywords

Kidney graft; Outcome; Patient survival; Proteinuria; Risk factor

Indexed keywords

CREATININE; CYCLOSPORIN A; LYMPHOCYTE ANTIBODY; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; OKT 3; PANEL REACTIVE ANTIBODY; PREDNISONE; RAPAMYCIN; TACROLIMUS;

ACUTE GRAFT REJECTION; ADULT; ARTICLE; BLOOD PRESSURE MONITORING; COLD ISCHEMIA; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DELAYED GRAFT FUNCTION; DIABETES MELLITUS; DOSE RESPONSE; DRUG MEGADOSE; FEMALE; FOLLOW UP; GRAFT RECIPIENT; GRAFT SURVIVAL; HLA MATCHING; HUMAN; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; PROTEIN URINE LEVEL; PROTEINURIA; RISK FACTOR;

ADULT; CREATININE; FEMALE; GRAFT SURVIVAL; HUMANS; KAPLAN-MEIERS ESTIMATE; KIDNEY TRANSPLANTATION; MALE; MULTIVARIATE ANALYSIS; PROGNOSIS; PROTEINURIA; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 77952939020     PISSN: 09020063     EISSN: 13990012     Source Type: Journal    
DOI: 10.1111/j.1399-0012.2009.01043.x     Document Type: Article

References (33)

1. Solez K, Vicenti F, Filo RS. Histopathology from 2-year biopsies from a U.S. multicenter kidney transplant trial-comparing tacrolimus versus cyclosporine: a report of the FK506 Kidney Transplant Study Group. Transplantation 1998, 66:1736.
2. Kang CM, Kim GH, Lee CH, Kwak JY, Kwon OJ. Analysis of allograft biopsy specimens in renal transplants with proteinuria: is proteinuria a culprit of graft loss? Transplant Proc 2005, 37:984.
3. Wormer KL, Vella JP, Sayegh M. Chronic allograft dysfunction: mechanisms and new approaches to therapy. Semin Nephrol 2000, 30:126.
4. Bruzzi I, Benigni A, Remuzzi G. Role of increased glomerular protein traffic in the progression of renal failure. Kidney Int 1997, 52:S29.
5. Ruggenti P, Perna A, Gherardi G. Renoprotective properties of ACE inhibition in nondiabetic nephropathies with non-nephrotic proteinuria. Lancet 1999, 354:359.
6. Paul LC, Sijpkens YW. Surrogate end points in chronic kidney graft rejection studies. Transplant Proc 1999, 31:1293.
7. Halimi JM, Laouad I, Buchler M. Early low-grade proteinuria: causes, short-term evolution and long-term consequences in renal transplantation. Am J Transplant 2005, 5:2281.
8. Halimi JM, Buchler M, Al-Najjar A. Urinary albumin excretion and the risk of graft loss and death in proteinuric and non-proteinuric renal transplant recipients. Am J Transplant 2007, 7:618.
9. Kamar N, Frimat Luc, Blancho G, Wolff PH, Delahousse M, Rostaig L. Evaluation of the efficacy and safety of a slow conversion from calcineurin inhibitor to sirolimus-based therapies in maintenance renal-transplant patients presenting with moderate renal insufficiency. Transpl Int 2007, 20:128.
10. Massy ZA, Guijarro C, Wiederkehr MR, Ma JZ, Kasiske BL. Chronic renal allograft rejection: immunologic and nonimmunologic risk factors. Kidney Int 1996, 49:518.
11. Broekroelsofs J, Stegman CA, Navis G. Risk factors for long-term renal survival after renal transplantation: a role for angiotensin-converting enzyme (insertion/deletion) polymorphism? J Am Soc Nephrol 1998, 9:2075.
12. Wilmer WA, Rovin Brad H, Hebert CJ. Management of glomerular proteinuria: a commentary. J Am Soc Nephrol 2003, 14:3217.
13. Jafar TH, Schmidt CH, Landa M. Angiotensin-converting enzyme inhibitors and progression of non-diabetic renal disease. A meta-analysis of patient-level data. Ann Intern Med 2001, 135:73.
14. Ruggenenti P, Schieppati A, Remuzzi G. Progression, remission, regression of chronic renal diseases. Lancet 2001, 357:1601.
15. Sancho A, Gavela E, Avila A. Risk factors and prognosis for proteinuria in renal transplant patients. Transplant Proc 2007, 39:2145.
16. Barnas U, Schmidt A, Haas M. Parameters associated with chronic renal transplant failure. Nephrol Dial Transplant 1997, 12:82.
17. Fernandez-Fresnedo G, Escallada R, Rodrigo E. The risk of cardiovascular disease associated with proteinuria in renal transplant patients. Transplantation 2002, 73:1345.
18. Legendre C, Thervet E, Skhiri H. Histologic features of chronic allograft nephropathy by protocol biopsies in kidney transplant recipients. Transplantation 1998, 65:1506.
19. Girardin C, Mihatsch MJ, Morelon E, Peraldi MN, Brousse N, Kreis H. Histologic findings from -6 months, 2 years and 10 years after transplantation sequential protocol biopsies in kidney transplant recipients. Nephrol Dial Transplant 2001, 16.
20. Keane WF. Proteinuria, its clinical importance and role in progressive renal disease. Am J Kidney Dis 2000, 35(Suppl. 1):S97.
21. Cantarovich F, Thervet E, Heguilen R. Angiotensin converting enzyme inhibitors and Sartans in cadaveric kidney transplantation. Am J Transplant 2006, 6(Suppl. 2):665.
22. Remuzzi G, Bertani T. Pathophysiology of progressive nephropathies. N Engl J Med 1998, 339:1448.
23. D'Amico G, Ferrario F, Rastaldi MP. Tubulointerstitial damage in glomerular diseases: its role in the progression of renal damage. Am J Kidney Dis 1995, 26:124.
24. Zoja C, Corna D, Camozzi D. How to fully protect the kidney in a severe model of progressive nephropathy: a multidrug approach. J Am Soc Nephrol 2002, 13:2898.
25. Reichel H, Zeier M, Ritz E. Proteinuria after renal transplantation: pathogenesis and management. Nephrol Dial Transplant 2004, 19:301.
26. Cantarovich F, Carbajal R, Medioni J. Clinical evaluation of early predictors of renal transplantation results. Transplant Proc 2001, 33:1192.
27. Roodnat J, Mulder PG, Rischen-Vos J, van Riemsdijk IC, van Gelder T. Proteinuria after renal transplantation affects not only graft survival but also patient survival. Transplantation 2001, 72:438.
28. Fernandez Fresnedo G, Plaza JJ, Sanchez-Plumed J. Proteinuria: a new marker of long-term graft and patient survival in kidney transplantation. Nephrol Dial Transplant 2004, 19:iii47.
29. Fontan MP, Rodriguez-Carmona A, FalconT G, Valdes F. Early proteinuria in renal transplant recipients treated with cyclosporin. Transplantation 1999, 67:561.
30. Bombas A, Stein-Oakley AN, Baxter K, Thomson NM, Jablonski P. Development of injury in a rat model of chronic renal allograft rejection: effect of dietary protein restriction. Transplant Int 1999, 12:18.
31. Borchhardt K, Haas M, Yilmaz N. Low dose angiotensin converting enzyme inhibition and glomerular permselectivity in renal transplant recipients. Kidney Int 1997, 52:1622.
32. Grekas D, Dioudis C, Kalevrosoglou I. Management of moderate to severe hypertension and proteinuria by nifedipine retard and perindopril alter renal transplantation. Clin Nephrol 1995, 44:299.
33. Hariharan S. Long term kidney transplant survival. Am J Kidney Dis 2001, 38:S44.